Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$216K Sell
887
-647
-42% -$159K 0.16% 120
2022
Q1
$371K Buy
1,534
+31
+2% +$7.12K 0.08% 145
2021
Q4
$338K Sell
1,503
-273
-15% -$57.6K 0.07% 168
2021
Q3
$378K Sell
1,776
-32
-2% -$7.37K 0.09% 149
2021
Q2
$441K Sell
1,808
-21
-1% -$5.17K 0.1% 128
2021
Q1
$455K Sell
1,829
-1,531
-46% -$365K 0.11% 119
2020
Q4
$773K Sell
3,360
-23
-0.7% -$5.3K 0.14% 109
2020
Q3
$860K Sell
3,383
-90
-3% -$22.3K 0.18% 83
2020
Q2
$819K Buy
3,473
+11
+0.3% +$2.51K 0.18% 86
2020
Q1
$702K Buy
3,462
+697
+25% +$152K 0.18% 86
2019
Q4
$666K Buy
2,765
+126
+5% +$27.8K 0.14% 94
2019
Q3
$511K Buy
2,639
+293
+12% +$56.2K 0.09% 140
2019
Q2
$433K Sell
2,346
-673
-22% -$121K 0.1% 132
2019
Q1
$574K Buy
3,019
+271
+10% +$51.8K 0.11% 123
2018
Q4
$535K Buy
2,748
+338
+14% +$65.9K 0.12% 120
2018
Q3
$499K Sell
2,410
-64
-3% -$12.6K 0.1% 138
2018
Q2
$456K Buy
2,474
+112
+5% +$19.8K 0.1% 142
2018
Q1
$403K Sell
2,362
-135
-5% -$24.8K 0.09% 152
2017
Q4
$434 Buy
+2,497
New +$442K 0.1% 134

Other funds holding AMGN

Private Capital Group's AMGN Position: Q2 2022 in Review

Private Capital Group reduced its Amgen (AMGN) stake by 42% in Q2 2022, selling an estimated $159K and leaving 887 shares worth $216K. The position accounts for 0.16% of the portfolio, ranked #120.

Private Capital Group first reported a position in AMGN in Q4 2017 and has held it in 19 quarters since. The position peaked at $860K in Q3 2020. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Private Capital Group held 887 shares of Amgen worth $216K as of Q2 2022.
  • Private Capital Group sold 647 Amgen shares in Q2 2022, an estimated $159K.
  • Amgen made up 0.16% of Private Capital Group's portfolio in Q2 2022, its #120 holding.
  • Private Capital Group first reported a position in Amgen in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Amgen position peaked at $860K in Q3 2020.
  • 2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.